Market access teams routinely make high-stakes decisions with incomplete information and compressed timelines. Primary market research remains the gold standard, but in-depth interviews with payers are expensive, logistically complex, and difficult to repeat iteratively as strategy and data evolves. The result is that value messaging frameworks, Target Product Profile (TPP) assumptions, and pricing strategies often have limited payer testing before they meet real payers.